We have known the Belgian Cancer Registry for many years as a partner on which the NIHDI can always rely. Their accuracy, professionalism, expertise, and reliability make our collaboration not only efficient but also highly pleasant.

Thanks to BCR, paediatric oncology in Belgium has been structurally recognised and integrated into European registry data. The ‘late effects’ project also provides an essential contribution to further therapy optimisation and quality improvement.

For 20 years, we have worked together to deepen knowledge and understanding, to ensure data completeness and data quality — because each registration contributes to better care for tomorrow.

BSP and BCR are complementary: yesterday, today, and especially tomorrow. The cancer registry is the crucial lever that transforms our microscopic pathological diagnostics from  individual findings into collective health benefit.

The BCR makes extremely important contributions to improvements in oncological treatments in our country. Efficiency, reliability, and enthusiasm are the qualities that characterise the BCR and have made it a beacon in Belgian healthcare.

Since its creation, the Belgian Cancer Registry has built a robust and reliable infrastructure for cancer data. This solid foundation creates unique opportunities to deepen scientific insights and societal impact through partnership.

Correct data and numbers are crucial, but we must not forget that they represent people.

Since its creation, the Belgian Cancer Registry has built a robust and reliable infrastructure for cancer data. This solid foundation creates unique opportunities to deepen scientific insights and societal impact through partnership.

Working collaboratively to collect, manage and analyse cancer data through a public‑utility organisation has been an indispensable pillar for 20 years for research, epidemiology, evidence‑based public health policy and international benchmarking.

The unique collaboration between the BCR and CvKO is driven by a shared passion for accurate and complete data which, through the correct linkages, help improve the lives of many Flemish citizens and enhance the quality of cancer screening.

Health data and data expertise lie at the heart of the work of both the BCR and the IMA. For many years, we have worked closely together to support data‑driven policy, monitor health‑care developments and gain scientific insights.
Complementarity and the exchange of expertise are central within our collaboration. This enables both organisations to achieve high‑quality results more quickly and fulfil our missions.

Our collaboration with the BCR is a model of trust and progress: an agile, knowledgeable partner who thinks together with us, responds quickly, and consistently supports us with up‑to‑date and accurate insights in a constantly evolving regulatory landscape.

Thanks to the close collaboration and support of the Belgian Cancer Registry, the Flemish Institute for Quality of Care succeeded in developing valid quality indicators in oncology as a basis for more transparent and better care in Flanders.

The data and analyses produced by the Cancer Registry are used daily by the Health and Social Observatory (Vivalis) to better understand cancer-related issues and to help improve the health of Brussels residents.

The Cancer Registry Foundation is indispensable for public health. Kom op tegen Kanker, the government, and healthcare providers rely on its data and analyses to improve cancer prevention and cancer treatment.
 

The partnership with the Belgian Cancer Registry enables us to turn highquality cancer data into epidemiological evidence that supports better research, prevention, and decision-making for the years ahead.

20 years of cancer registration, a major step forward. Today, knowledge and collaboration matter; tomorrow, hope and care for every patient will grow.